Nasopharyngeal cancer – pipeline review, h2 2012
Aarkstore Enterprise || Nasopharyngeal Cancer – Pipeline Review, H2 2012
Published on: Mar 3, 2016
Transcripts - Nasopharyngeal cancer – pipeline review, h2 2012
Aarkstore.com announces, The Latest market research report is available inits vast collection:Nasopharyngeal Cancer – Pipeline Review, H2 2012RSS link of Global Markets DirectSummaryGlobal Markets Direct’s, Nasopharyngeal Cancer - Pipeline Review, H2 2012,provides an overview of the Nasopharyngeal Cancer therapeutic pipeline. Thisreport provides information on the therapeutic development for NasopharyngealCancer, complete with latest updates, and special features on late-stage anddiscontinued projects. It also reviews key players involved in the therapeuticdevelopment for Nasopharyngeal Cancer. Nasopharyngeal Cancer - Pipeline Review,H2 2012 is built using data and information sourced from Global Markets Direct’sproprietary databases, Company/University websites, SEC filings, investorpresentations and featured press releases from company/university sites andindustry-specific third party sources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Nasopharyngeal Cancer.- A review of the Nasopharyngeal Cancer products under development bycompanies and universities/research institutes based on information derived fromcompany and industry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combinedtherapeutics.Table of contents:List of Tables 4List of Figures 5Introduction 6Global Markets Direct Report Coverage 6Nasopharyngeal Cancer Overview 7Therapeutics Development 8An Overview of Pipeline Products for Nasopharyngeal Cancer 8Nasopharyngeal Cancer Therapeutics under Development by Companies 10Nasopharyngeal Cancer Therapeutics under Investigation by Universities/Institutes11Late Stage Products 14Comparative Analysis 14Mid Clinical Stage Products 15Comparative Analysis 15Early Clinical Stage Products 16Comparative Analysis 16Pre-Clinical Stage Products 17Comparative Analysis 17Nasopharyngeal Cancer Therapeutics – Products under Development by Companies18Nasopharyngeal Cancer Therapeutics – Products under Investigation byUniversities/Institutes 19Companies Involved in Nasopharyngeal Cancer Therapeutics Development 21F. Hoffmann-La Roche Ltd. 21YM BioSciences Inc. 22Cyclacel Pharmaceuticals Inc. 23Jiangsu Hengrui Medicine Co., Ltd. 24Biotech Pharmaceuticals Co., Ltd. 25Nasopharyngeal Cancer – Therapeutics Assessment 26Assessment by Monotherapy Products 26Assessment by Combination Products 27
Assessment by Route of Administration 28Assessment by Molecule Type 30Drug Profiles 32Seliciclib - Drug Profile 32Vorinostat + Capecitabine - Drug Profile 34Cetuximab + Cisplatin - Drug Profile 36Cisplatinum + Radiotherapy - Drug Profile 38List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H2 2012http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H22012&PubId=&pagenum=1Nasopharyngeal Cancer – Pipeline Review, H2 2012Medulloblastoma – Pipeline Review, H2 2012Ewing Sarcoma – Pipeline Review, H2 2012Respiratory Syncytial Virus (RSV) Infections – Pipeline Review, H2 2012Equine Encephalitis – Pipeline Review, H2 2012Anaplastic Astrocytoma – Pipeline Review, H2 2012
Penile Cancer – Pipeline Review, H2 2012Natural Killer Cell Lymphomas – Pipeline Review, H2 2012Medullary Thyroid Cancer – Pipeline Review, H2 2012Fever – Pipeline Review, H2 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: email@example.com